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Abstract
OBJECTIVE—To describe the metabolic profile of individuals with objective binge eating 
(OBE) and to evaluate whether associations between OBE and metabolic risk factors are mediated 
by body mass index (BMI).
DESIGN AND METHODS—Participants from the Framingham Heart Study, Third Generation 
and Omni 2 cohorts (n = 3551, 53.1% women, mean age 46.4 years) were screened for binge 
eating. We used multivariable-adjusted regression models to examine the associations of OBE 
with metabolic risk factors.
RESULTS—The prevalence of OBE was 4.8% in women and 4.9% in men. Compared to non-
binge eating, OBE was associated with higher odds of hypertension (OR 1.85, 95% CI 1.32–2.60), 
hypertriglyceridemia (OR 1.42, 95% CI 1.01–2.01), low HDL (OR 1.70, 95% CI 1.18–2.44), 
insulin resistance (OR 3.18, 95% CI 2.25–4.50) and metabolic syndrome (OR 2.75, 95% CI 1.94–
3.90). Fasting glucose was 7.2 mg/dl higher in those with OBE (p=0.0001). Individuals with OBE 
had more visceral, subcutaneous and liver fat. Most of these associations were attenuated with 
adjustment for BMI, with the exception of fasting glucose.
CONCLUSIONS—Binge eating is associated with a high burden of metabolic risk factors. Much 
of the associated risk appears to be mediated by BMI, with the exception of fasting glucose.
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INTRODUCTION
Obesity is a significant health problem in the United States, affecting more than one-third of 
U.S. adults and increasing the risk for type 2 diabetes, coronary heart disease and all-cause 
mortality.1, 2 Despite awareness of this problem, effective strategies to prevent obesity have 
been elusive.
“Binge eating” is a behavior marked by consumption of large amounts of food in a short 
time frame, accompanied by a sense of lack of control over eating. “Binge eating disorder” 
(BED) is a condition of chronic and recurrent binge eating (at least once-weekly for 3 
months) without compensatory behavior such as purging.3 It is thought to be the most 
common eating disorder in the US, and is particularly prevalent in obese people seeking 
treatment, among whom BED prevalence may be 30% or greater.4 Treatment seeking 
individuals with BED have high rates of metabolic syndrome (32–60%).5–7 Estimates of 
BED prevalence among individuals with type 2 diabetes from small clinic-based samples 
have varied widely, from 2.5% to over 25%.8–11 A five-year longitudinal study of 134 
individuals with BED compared to controls matched for age, sex and body mass index 
(BMI) showed that BED was associated with an increased risk for reporting one or more 
components of the metabolic syndrome, even after adjustment for baseline BMI, suggesting 
the possibility of non-BMI-mediated mechanisms.12 If these associations are present in the 
general population, binge eating may represent an important clinical target for identifying 
individuals at high risk for obesity and adverse metabolic outcomes.
While prior work has pointed to a strong association between BED and obesity, and a high 
rate of metabolic syndrome among selected treatment-seeking obese individuals with BED, 
a detailed metabolic characterization of individuals with binge eating derived from the 
general adult population has not been carried out. Studies that make use of directly measured 
risk factors, which are not susceptible to reporting bias, are needed. Thus, the purpose of the 
present investigation was to examine the association between binge eating behavior and 
metabolic outcomes in a large population-based cohort with robust measurement of risk 
factors, and further to examine whether observed associations were mediated by BMI. A 
formal diagnosis of BED requires associated psychiatric symptoms which we did not assess, 
thus we used the term objective binge eating (OBE) to describe individuals who fulfilled 
behavioral criteria for BED.
We also sought to characterize the metabolic risk associated with “subjective binge eating 
(SBE),” which describes the sensation of loss of control over eating without objective 
overeating.13 SBE appears to be a less severe manifestation of binge eating, however it is 
still associated with obesity and psychological stressors of disordered eating.13, 14 When 
grouped together, OBE and SBE are termed “loss of control eating.” We hypothesized that 
binge eating would be associated with an increased burden of metabolic risk factors and that 
some of this burden would be independent of BMI.
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METHODS
Study Sample
The Framingham Heart Study is a large population-based cohort study of cardiovascular 
disease and its risk factors, which started in Framingham, Massachusetts in 1948, beginning 
with the Original Cohort.15 Participants in the current study were drawn from the Third 
Generation (Exam 2) and Omni 2 (Exam 2) Cohorts.
Recruitment of the Third Generation began in November 2001. The second examination 
cycle began in 2008 and continued through 2011. A total of 3411 participants completed the 
exam, of whom 3375 answered questions about binge eating and provided blood samples. 
After excluding individuals with missing covariates, 3272 participants from Generation 3 
Exam 2 were available for analysis.
The Omni cohorts were initiated in 1994 to reflect the increasing ethnic diversity of the 
community; they include African-American, Hispanic, Asian, Indian, Pacific Islander and 
Native American participants. Recruitment of the second Omni cohort began in 2003. Omni 
2 exam 2 ran from 2009 through 2011 and was contemporaneous with the second 
examination of the Third Generation cohort. A total of 321 participants completed the exam, 
of whom 318 answered questions about binge eating and provided blood samples. After 
excluding individuals with missing covariates, 279 participants from Omni 2 Exam 2 were 
available for analysis. Thus the total sample size was 3551.
Study protocols and procedures were approved by the institutional review board at Boston 
University. Written informed consent was obtained from all participants.
Binge Eating Assessment
We assessed patterns of binge eating using questions drawn from a standard questionnaire 
(Questionnaire on Eating and Weight Patterns-Revised) that is widely used for the diagnosis 
of BED.16 The current study was designed using the definition of BED in the prior version 
of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which differs from 
the most recently published definition (DSM-5) in duration and frequency of binge eating.17
Participants were asked “Do you often feel that you can’t control what or how much you 
eat?” and “Do you often eat, within any 2-hour period, what most people would regard as an 
unusually large amount of food?” If participants responded yes to either of these questions, 
they were then asked to quantify the frequency of this behavior over the previous 6 months. 
Choices were “Less than once per month,” “Once per month,” “Two to three times per 
month,” “Once per week,” and “Twice per week or more.” “Clinical OBE” was defined as 
“Yes” to the first two questions followed by a frequency of “Twice per week or more” for 
the third question. “Subclinical OBE” was defined as “Yes” to the first two questions 
followed by any of the lesser frequencies in response to the third question. SBE was defined 
as “Yes” to the first question about uncontrolled eating but “No” to the second question. 
Individuals who answered “No” to the first question were deemed non-binge eating (NBE).
Abraham et al. Page 3
Obesity (Silver Spring). Author manuscript; available in PMC 2015 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Metabolic Risk Factor Assessment
Key metabolic risk factors were measured at the contemporaneous examination. BMI, 
defined as weight in kilograms (assessed using a Detecto scale, Webb City, Missouri) 
divided by the square of the height in meters was measured as part of each examination 
cycle. Seated systolic and diastolic blood pressures were measured on site manually using a 
mercury column sphygmomanometer. Waist circumference was measured at the level of the 
umbilicus and reported to the nearest quarter inch. Plasma glucose, insulin (for HOMA-IR 
calculation), total cholesterol, HDL cholesterol, triglycerides, AST and ALT were measured 
from fasting morning samples. Insulin was measured via enzyme-linked immunosorbent 
assay (Roche e411 immunochemistry analyzer).
Hypertension was defined as systolic blood pressure ≥ 140 mm Hg, diastolic blood pressure 
≥ 90mm Hg or on treatment. Hypertriglyceridemia was defined as triglycerides > 150 mg/dL 
or on lipid-lowering treatment. Low HDL was defined as < 40mg/dL in men or < 50mg/dL 
in women. Type 2 diabetes was defined as a fasting glucose ≥ 126 mg/dL, casual glucose ≥ 
200 mg/dL or on diabetes treatment. Metabolic syndrome was defined using modified ATP 
III criteria.18 Obesity was defined as BMI ≥ 30 kg/m2. HOMA-IR was dichotomized at the 
75th percentile; individuals with diabetes were excluded for all HOMA-IR analyses.
Finally as a summary measure, we calculated the Framingham risk score (FRS), which 
estimates the 10-year risk of any cardiovascular event including coronary, cerebrovascular 
and peripheral arterial disease and heart failure.19 The score is derived from a composite of 
age, blood pressure, cholesterol, smoking status, and the presence of diabetes.
Multidetector CT Substudy
A subset (n=1496) of participants underwent multidetector computed tomography of the 
chest and abdomen using Discovery VCT 64-slice PET/CT scanner (GE Healthcare). 
Beginning at approximately 2 cm above the S1 vertebrae, 30 contiguous 5-mm thick slices 
(120kVP; 100–300mA dependent on BMI) were acquired. Subcutaneous adipose tissue 
(SAT) and visceral adipose tissue (VAT) volumes were assessed (Aquarius 3D Workstation, 
TeraRecon Inc., San Mateo, CA). To determine fat quality, an image display window width 
of −195 to −45 Hounsfield units (HU) and a window center of −120 HU were used. The 
abdominal muscular wall separating the visceral and subcutaneous compartments was traced 
manually. Inter-reader reproducibility was assessed by 2 independent readers measuring 
VAT and SAT on a subset of 46 randomly selected participants. Intra-reader correlations 
were 0.99 for VAT and 0.99 for SAT.
Liver attenuation, as a marker of liver fat, was measured in HU, as we have previously 
reported.20 Additionally, a calibration phantom with a water equivalent compound (CT-
Water, Light Speed Ultra; General Electric, Milwaukee, WI) and calcium hydroxyapatite 
was placed under each participant. This was used to calculate a liver-to-phantom ratio (LPR) 
of the participant’s liver fat divided by the phantom fat in HU. LPR is thus an indexed 
unitless standard with a lower value indicating higher liver fat content.21
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Assessment of Covariates
Covariates were ascertained via interview or measured directly at the contemporaneous 
examination. These included age, sex, body mass index, height, ethnicity and education 
status. Current smoking was assessed via physician interview at the time of examination and 
defined as smoking at least 1 cigarette daily for the previous year. Alcohol intake 
(dichotomized at > 14 drinks/week in men or > 7 drinks/week in women) was quantified by 
a series of questions at the physician interview. Depressive symptoms were assessed via 
Center for Epidemiologic Study Scale (CES-D) with a score of 16 or greater required for 
diagnosis of depressive symptoms.22
Statistical Analysis
The binge eating groups were first characterized by standard demographic, anthropometric 
and laboratory parameters. The characteristics of patients with clinical and subclinical OBE 
were generally similar and approximately 90% of individuals designated as subclinical OBE 
reported a frequency of either “Two to three times per month” or “Once per week” 
(Supplemental Table 1). Thus clinical and subclinical OBE were merged into a single group 
called OBE for subsequent analyses. Overall, age-specific and sex-specific prevalence of 
binge eating behaviors were calculated.
We first performed an ANOVA to test whether there was a significant difference among 
binge eating groups. We then pursued pairwise comparisons (OBE compared to NBE and 
SBE compared to NBE) to better characterize the nature of the differences. Multivariable-
adjusted linear and logistic regression models were used to assess the relationship between 
binge eating status and metabolic risk factors (continuous and dichotomized). The first 
multivariable model included adjustment for age, sex, smoking history, alcohol intake, 
education and depressive symptoms. Model 2 was additionally adjusted for BMI. Finally we 
tested the interaction between OBE and BMI for each metabolic risk factor (continuous and 
dichotomized). To characterize the direction of significant interactions, we then performed 
multivariable adjusted regression analyses stratified by BMI category (normal weight, 
overweight or obese) as exploratory analyses.
All statistical analyses were conducted using SAS version 9.3. We considered two-tailed p 
values <0.05 to be statistically significant; there was no adjustment for multiple 
comparisons.
RESULTS
Study Sample Characteristics
Demographic and descriptive characteristics for the overall cohort and for categories of 
binge eating are shown in Table 1. The mean age was approximately 46.6 years and slightly 
more than half were women.
The overall prevalence of OBE was nearly 5% (4.9% among men, 4.8% among women); the 
overall prevalence of SBE was 7.1% (4.7% among men, 9.2% among women) (Table 2). 
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Binge eating prevalence was not significantly different among age groups (p=0.43) and was 
more common among obese and overweight individuals (p <0.0001).
Metabolic Characterization of Patients with OBE and SBE
There was a significant difference (ANOVA p<0.01) among binge eating groups for nearly 
all outcomes (continuous and dichotomous). Thus, we pursued multivariable-adjusted 
regression models with pairwise comparisons. OBE was associated with more adverse levels 
of several metabolic parameters (Table 3) compared to NBE. For example, systolic blood 
pressure was 3.6 mm Hg higher (p=0.001) in OBE compared to NBE. HDL-cholesterol was 
4.3 mg/dL lower (p=0.0009), fasting glucose was 7.2 mg/dL higher (p<0.0001), and ALT 
was 4.3 mg/dL higher (p=0.002) in individuals with OBE. Among the participants in the CT 
substudy, those with OBE had higher VAT volume (+522.5 cm3, p=0.0003), higher SAT 
volume (+1012.5 cm3, p< 0.0001) and more fatty liver (−5.9 HU, p=0.0001). After BMI 
adjustment, these associations were no longer significant with the notable exception of 
fasting glucose. After adjustment for BMI, fasting glucose remained 4.3 mg/dL higher (p = 
0.001) among individuals with OBE. For individuals with SBE, several outcomes including 
fasting glucose were higher compared to NBE (Table 3). However, these differences did not 
persist when additional adjustment for BMI was performed.
Based on the Framingham risk score, individuals with OBE had a 1.6% higher 10-year risk 
of a CVD event compared to NBE (p < 0.0001); SBE had a 0.9% higher 10-year risk 
(p=0.002, Table 3). These results were also attenuated by BMI adjustment.
Results for dichotomized outcomes are shown in Table 4. Individuals with OBE had a 
higher burden of metabolic risk factors including hypertension (OR 1.85, 95% CI 1.32–
2.60), low HDL (OR 1.70, 95% CI 1.18–2.44), type 2 diabetes (OR 2.95, 95% CI 1.75–4.96) 
and metabolic syndrome (OR 2.75, 95% CI 1.94–3.90) compared to NBE participants. 
These associations were attenuated when additionally adjusting for BMI. Results were 
similar for SBE. We found significant interactions between BMI and OBE for several 
outcomes (Tables 5 and 6). To characterize significant interactions, we performed 
exploratory analyses examining the associations between OBE and outcomes stratified by 
BMI category. For the continuous outcomes, the effects were somewhat stronger among 
obese individuals. For dichotomous outcomes, if there was an interaction, it was that the 
relationship between OBE and the outcome was stronger among normal weight individuals 
and was attenuated in obese individuals. For example, the odds ratios of OBE for type 2 
diabetes and metabolic syndrome were higher in normal weight individuals than in obese 
individuals.
After data collection was completed for the present study, the definition of BED was revised 
in the DSM-5.3 The duration and frequency required for diagnosis was reduced to “once per 
week or more for three months.” Because of this new definition, we conducted a secondary 
analysis of OBE using a frequency of “once per week or more for six months” (the closest 
approximation to the current definition available from the data we collected). This secondary 
analysis did not change the findings substantially; these results are included in 
Supplementary Tables 3 and 4.
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DISCUSSION
Principal Findings
Our principal findings are threefold. First, our study demonstrates that binge eating is 
common, with approximately 5% of our sample reporting OBE; this was equal across 
gender and age groups. An additional 7% of our sample (9.2% of woman, 4.7% of men) 
reported SBE. Second, individuals with OBE have a high burden of metabolic risk factors 
including obesity, hypertension, hypertriglyceridemia, and type 2 diabetes compared to 
NBE. They had more visceral, subcutaneous and hepatic fat. SBE, which consists only of 
the feeling of a lack of control over eating without reported objective overeating episodes, 
also carried a higher risk of obesity and type 2 diabetes. Third, the increased metabolic risk 
factors associated with OBE and SBE are largely attenuated after adjusting for BMI, 
suggesting that much of the risk factor burden is mediated by excess body weight. A notable 
exception was fasting glucose, which was higher in those with OBE even after BMI 
adjustment.
There were several significant interactions between OBE and BMI. The analysis stratified 
by BMI category found that the association of OBE with continuous outcomes was stronger 
among obese, while the association with dichotomous outcomes was stronger in normal 
weight individuals and was less pronounced in obese individuals. This pattern is likely due 
to the lower baseline risk among normal weight individuals.
In the Context of the Current Literature
Our findings expand upon previous work that demonstrated associations with metabolic 
syndrome in treatment-seeking overweight and obese samples with BED.5, 6, 23 In our large 
community-based sample that included individuals across the body weight spectrum, we 
observed higher odds ratios for obesity and metabolic syndrome in those with OBE 
compared to NBE. Our results demonstrate a higher burden of risk factors among binge 
eaters across a wide range of metabolic function. Our findings show that binge eating is a 
relevant problem in the general population and that individuals who binge eat are at high 
risk for cardiovascular disease.
Our findings differ from a prior longitudinal study of 268 individuals,12 which showed a 
higher risk for components of metabolic syndrome in BED that persisted after adjustment 
for BMI. There are some important differences which may explain our disparate findings. 
First, the sample was drawn from treatment-seeking overweight and obese people with mean 
baseline BMI ~35 kg/m2. Second, the baseline prevalence of metabolic syndrome was low 
(2.5%), suggesting the possibility of under-ascertainment. Metabolic risk factors were self-
reported, which may be less accurate and thus quantification of associations less reliable.
Our findings also demonstrated that individuals with OBE and SBE had higher volumes of 
VAT and SAT; the fat quality assessments showed lower Hounsfield unit attenuation, which 
we have previously shown to be associated with more adverse metabolic risk factor 
profiles.24 These results add to the clinical picture of higher metabolic burden in individuals 
with binge eating.
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Potential Mechanisms
Our results demonstrate that binge eating is associated with a host of adverse metabolic 
factors including type 2 diabetes, hypertension and measures of ectopic fat including liver 
fat and visceral fat. The association with obesity explains much of this metabolic burden. A 
notable exception was fasting glucose, which was higher among individuals with OBE even 
after BMI adjustment. We considered the possibility that some individuals with OBE in our 
sample may have binge eaten overnight prior to their blood draw and thus their samples 
were truly non-fasting. If this had been the case however, one might have expected that 
triglycerides would similarly have been elevated independent of BMI, but this was not 
observed. Therefore, this is unlikely to fully explain our findings.
Further research is needed to confirm and explore the finding of BMI-independent higher 
fasting glucose among OBE individuals, however the published literature suggests several 
potential mechanisms that may explain the association.
Leptin is a hormone produced by adipose tissue that reduces hepatic glucose production via 
suppression of glucagon.25 In normal physiology, the majority of fasting glucose production 
is derived from the liver due to a combination of glycogenolysis and gluconeogenesis.26 One 
prior study found that ingestion of an entire day’s caloric intake in a single meal caused 
higher fasting glucose and impaired the normal post-prandial leptin response.27 Thus, the 
observed BMI-independent fasting glucose elevation among OBE individuals in the present 
study may be due to binge eating causing insufficient leptin production.
Another possibility is that binge eating may disrupt adipocytokines, which in turn have 
important mediatory effects on metabolic pathways. For example, adiponectin levels are 
reduced in women with BED compared to healthy women.28 Adiponectin mediates both 
gluconeogenesis and fatty acid oxidation, and promotes insulin sensitivity.28, 29 Deficiency 
of adiponectin may lead to higher fasting glucose among binge eaters.
Finally it is possible that concentration of caloric intake over a short period causes more 
sustained peaks in glucose and insulin related to rapid absorption. One study found that 
ingestion of daily food intake over 3 larger meals compared to over 13 smaller snacks, with 
calories held constant, resulted in higher mean glucose and insulin levels.30 The authors 
attributed these differences to the rate at which calories were presented to the body.
Implications
Our findings suggest that binge eating is particularly prevalent among obese individuals. It 
is associated with a significant burden of metabolic factors that are known to increase the 
risk for cardiovascular disease and mortality. In the present study, individuals with OBE and 
SBE had a higher estimated 10-year risk of CVD based on Framingham risk score. This 
result suggests that metabolic risk factors and cardiovascular disease may represent 
significant co-morbidities in individuals with binge eating. Furthermore, the observation that 
not all of the higher fasting glucose associated with binge eating is mediated by BMI merits 
further investigation to elucidate hormonal pathways and other mechanisms at play in 
conferring this risk.
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Strengths and Limitations
There are several strengths to our study. First, our cohort was drawn from the community-
based Framingham Heart Study. Metabolic risk factors were well-characterized and we did 
not depend on self-report. In addition, our sample was large, lending more power to detect 
differences. Finally, we were able to look across a broad spectrum of binge eating behaviors. 
Some limitations warrant mention. Our population is primarily Caucasian, limiting 
generalizability to other races/ethnicities. The cross-sectional design precludes inference of 
temporality. Because our study is observational, we cannot infer causality between binge 
eating and associated risk factors. Another limitation is that we did not exclude the 
possibility that some individuals classified as binge eating may have met criteria for bulimia 
nervosa. Bulimia nervosa is also characterized by binge eating, but unlike BED includes 
inappropriate compensatory behaviors (such as purging, excessive exercise or fasting), 
which we did not assess.31 However, because bulimia nervosa is considerably less common 
than BED and tends to affect a younger subset of the population than that represented in our 
sample, this is unlikely to have significantly altered the results.32, 33 Finally, the use of 
questionnaire methods to assess binge eating may have led to an overestimation of its 
prevalence relative to that found by interview methods.34
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WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT?
Binge eating disorder is known to be prevalent among individuals seeking treatment for 
obesity.
Prior work has suggested that some associations between binge eating and metabolic risk 
factors may be independent of BMI.
WHAT DOES THIS STUDY ADD?
A detailed metabolic characterization of binge eating disorder from a large generally 
healthy adult population.
Most of the metabolic risk associated with binge eating disorder is mediated by BMI. Our 
results found that binge eating was associated with impaired fasting glucose after 
accounting for BMI, suggesting that binge eating may be associated with glucose 
metabolism independent of its associations with weight.
Our study found that binge eating is a common condition affecting men and women 
across age groups and carries a high burden of metabolic risk factors; thus it is an 
important contributor to metabolic and cardiovascular risk in the general population.
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Table 1
Characteristics of binge eating
Continuous Characteristics: mean (SD) except Triglycerides, Drinks/Week and Liver Phantom Ratio shown as 
Median (25th–75th percentile)
Categorical/Dichotomous Characteristics: n (%)
Objective binge eating 
(n=172)
Subjective binge eating 
(n=252)
Non-binge eating (n=3127)
Age, years 47.0 (9.3) 47.5 (9.4) 46.5 (9.1)
Women (%) 91 (52.9) 173 (68.7) 1620 (51.8)
Race/Ethnicity† (%)
White 167 (97.1) 245 (97.2) 2980 (95.3)
Hispanic 5 (2.9) 12 (4.8) 102 (3.3)
Black 5 (2.9) 5 (2.0) 79 (2.5)
Asian 1 (0.6) 5 (2.0) 82 (2.6)
Pacific Islander 1 (0.6) 0 (0.0) 2 (0.1)
Native American or Alaskan 2 (1.2) 3 (1.2) 40 (1.3)
Education (%)
 < High School 0 (0) 1 (0.4) 34 (0)
 High School Graduate 22 (12.8) 34 (13.5) 403 (12.9)
 Some College 63 (36.6) 87 (34.5) 886 (28.3)
 College Graduate 87 (50.6) 130 (51.6) 1804 (57.7)
BMI (kg/m2) 33.0 (7.0) 30.9 (6.9) 27.5 (5.4)
Waist Circumference (cm) 109 (17) 103 (17) 96 (15)
BMI>= 30 kg/m2 (%) 120 (69.8) 118 (46.8) 838 (26.8)
Physical Activity Index 35.8 (7.4) 35.6 (6.4) 36.5 (6.5)
Current Smokers (%) 27 (15.7) 17 (6.8) 333 (10.7)
VAT, cm3 2706 (1430) 2422 (1520) 2171 (1360)
SAT, cm3 4339 (1793) 4480 (1858) 3203 (1578)
VAT/SAT Ratio 0.70 (0.54) 0.58 (0.44) 0.72 (0.44)
VAT, HU −96 (7) −95 (6) −94 (7)
SAT, HU −107 (4) −108 (3) −106 (4)
ALT, mg/dL 29 (17) 23 (13) 25 (17)
AST, mg/dL 22 (9) 21 (8) 22 (10)
Liver Phantom Ratio (Median (25th–75th %ile) 0.35 (0.30–0.38) 0.35 (0.28–0.38) 0.36 (0.33–0.38)
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Objective binge eating 
(n=172)
Subjective binge eating 
(n=252)
Non-binge eating (n=3127)
Alcoholic Drinks/Week 1.0 (0.0–4.5) 1.5 (0.0–4.0) 3.0 (0.5–7.3)
High Alcohol Intake (%)(> 14/wk men or > 7/wk 
women)
15 (8.7) 22 (8.7) 466 (14.9)
Depressive symptoms (%)(CES-D ≥ 16) 44 (26.6) 37 (14.7) 255 (8.2)
Total CES-D 10.8 (9.4) 8.6 (8.7) 5.7 (6.9)
Diabetes (%) 21 (12.2) 28 (11.1) 138 (4.4)
Fasting glucose (mg/dL) 105 (31) 99 (22) 96 (17)
HOMA-IR£ > 75th %ile (%) 71 (47.0) 75 (33.5) 695 (23.3)
HOMA-IR£ 3.40 (2.54) 2.68 (1.97) 2.23 (1.72)
Low HDL Cholesterol‡ (%) 46 (26.7) 47 (18.7) 514 (16.5)
Hypertriglyceridemia†† (%) 65 (37.8) 87 (34.5) 929 (29.7)
Total Cholesterol, mg/dL 187 (44) 187 (36) 186 (35)
HDL Cholesterol, mg/dL 54 (17) 59 (17) 60 (18)
Triglycerides (mg/dL) 114 (79–152) 101 (74–143) 92 (67–132)
Hypertension (%) 55 (32.0) 67 (26.6) 669 (21.4)
Systolic Blood Pressure (mm Hg) 120 (13) 117 (14) 116 (14)
Diastolic Blood Pressure (mm Hg) 76 (9) 74 (9) 74 (9)
Metabolic Syndrome (%) 65 (37.8) 71 (28.2) 586 (18.7)
Lipid-lowering medication (%) 38 (22.1) 50 (19.8) 509 (16.3)
Anti-hypertension medication (%) 43 (25.0) 58 (23.0) 519 (16.6)
Framingham Risk Score, % 7.5 (8.5) 5.8 (6.0) 5.5 (5.9)
†
Participants permitted to self-identify as more than 1 race thus percentages add to > 100%
£
HOMA-IR analyses exclude participants with diabetes (n=150 for OBE, 223 for SBE, 2976 for NBE)
‡
Low HDL cholesterol is defined as < 40mg/dL in men or < 50mg/dL in women
††
Hypertriglyceridemia is defined as ≥ 150mg/dL
BMI=body mass index; VAT = visceral adipose tissue; SAT = subcutaneous adipose tissue; HU = Hounsfield units; ALT = alanine 
aminotransferase; AST = aspartate aminotransferase; CES-D = Center for Epidemiologic Studies Depression Scale; HOMA-IR = homeostatic 
model assessment for insulin resistance
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Table 2
Overall, Sex-Specific and Age-Specific Prevalence of binge eating
Objective binge eating Subjective binge eating Non-binge eating
Overall 4.8 (172) 7.1 (252) 88.1 (3127)
Gender
 Women 4.8 (91) 9.2 (173) 86.0 (1620)
 Men 4.9 (81) 4.7 (79) 90.4 (1507)
Age Strata:
 Age < 35 4.3 (15) 6.3 (22) 89.5 (314)
 35 ≤ Age < 45 4.7 (50) 6.3 (67) 89.0 (950)
 45 ≤ Age < 55 4.9 (71) 7.5 (109) 87.6 (1266)
 55 ≤ Age < 65 4.1 (31) 7.4 (45) 87.5 (531)
 Age ≥ 65 6.3 (5) 11.3 (9) 82.5 (66)
BMI Category
 Normal weight 1.5 (18) 4.1 (49) 94.4 (1124)
 Overweight 2.7 (34) 6.6 (85) 90.7 (1165)
 Obese 11.2 (120) 11.0 (118) 77.9 (838)
Data shown are % (n)
BMI = body mass index
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